Table 2. Logistic regression analysis of the association of treatment failure (death and failure) with potential explanatory factors*.
| Variables | Crude OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|
| Male gender | 4.46 (0.56–35.5) | 5.8 (0.61–56.6) |
| Age, y | 1.05 (1.01–1.09) | 1.06 (1.01–1.1) |
| Immigrant status | 1.18 (0.13–10.2) | 0.7 (0.07–6.6) |
| HIV seropositivity | 5 (0.76–32.6) | 2.5 (0.28–22.1) |
| Previous TB treatment >30 d | 0.7 (0.26–2.2) | 0.4 (0.11–1.3) |
| Streptomycin resistance | 1.35 (0.15–11.4) | 1.18 (0.13–10.69) |
| Ethambutol resistance | 1.74 (0.52–5.7) | 0.99 (0.29–3.3) |
| Pyrazinamide resistance | 1.65 (0.57–4.7) | 1.08 (0.35–3.3) |
| Fluoroquinolone resistance | 1.67 (0.32–8.6) | 0.86 (0.09–7.7) |
| Resistance to injectable second-line drugs | 1.16 (0.3–4.5) | 1.28 (0.31–5.2) |
| Resistance to all second-line drugs | 1.18 (0.34–3.9) | 1.35 (0.37–4.8) |
*OR, odds ratio; CI, confidence interval; TB, tuberculosis.